Redirect Notice

Looks like you clickedhttps://www.jnj.com/european-commission-approves-imbruvica-ibrutinib-in-a-fixed-duration-combination-regimen-for-adult-patients-with-previously-untreated-chronic-lymphocytic-leukaemia-cll

If you do not want to visit that page, you can close this browser tab.